NCT05749900
- Conditions
- HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
- Locations
-
- Severance Hospital, Yonsei University Health System Seoul, South Korea
Clinical trial condition
Explore clinical trials studying HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.
NCT05749900
NCT04722133